$21.06
-0.74-3.39%
At close: Jul 9, 5:00 PM EST
$20.87
-0.93-4.27%
Pre-Market: 4:41 AM EST
Adaptive Biotechnologies Corp Earnings Estimates
ADPTNASDAQ
Adaptive Biotechnologies Earnings Estimates, EPS & Revenue | NASDAQ:ADPT
Adaptive Biotechnologies (ADPT) is scheduled to report Q2 earnings on July 29, 2026. Analysts estimate EPS of $-0.13 and quarterly revenue of $66.08M.
In the most recent quarter (Q1), Adaptive Biotechnologies reported EPS of $-0.13, beating estimates of $-0.16 by 0.19%. Revenue came in at $70.87M, exceeding the estimate of $61.07M by 0.16%.
Adaptive Biotechnologies has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Adaptive Biotechnologies has averaged an EPS surprise of 0.25% and a revenue surprise of 0.15%.
Earnings Date
Jul 29
EPS Estimate
$-0.130
Quarterly Revenue Estimate
$66.08M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$295.41M
Adaptive Biotechnologies Earnings History
Analyze the earnings history of Adaptive Biotechnologies using advanced sorting and filters.
Loading calendar...
Adaptive Biotechnologies (ADPT) Earnings Per Share
The chart below shows Adaptive Biotechnologies's reported EPS compared to analyst estimates over recent quarters.
Adaptive Biotechnologies (ADPT) Revenue
The chart below shows Adaptive Biotechnologies's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Adaptive Biotechnologies (NASDAQ:ADPT) reporting earnings?
Adaptive Biotechnologies (ADPT) is scheduled to report earnings on July 29, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Adaptive Biotechnologies (NASDAQ:ADPT)?
The Actual EPS was $-0.13, which beat the estimate of $-0.16.
What were Adaptive Biotechnologies’s (NASDAQ:ADPT) revenues?
The Actual Revenue was $70.87M, which beat the estimate of $61.07M.
